{"id":245500,"date":"2011-07-10T15:45:11","date_gmt":"2011-07-10T15:45:11","guid":{"rendered":"http:\/\/eugenesis.com\/new-digital-pathology-vendor-welcome-to-digipath-inc\/"},"modified":"2011-07-10T15:45:11","modified_gmt":"2011-07-10T15:45:11","slug":"new-digital-pathology-vendor-welcome-to-digipath-inc","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/new-digital-pathology-vendor-welcome-to-digipath-inc.php","title":{"rendered":"New Digital Pathology Vendor &#8211; Welcome to DigiPath, Inc."},"content":{"rendered":"<div><p><span><em>A new digital pathology vendor hits the market today. &nbsp;Affordable and innovative solutions to meet both clinical and research\/biopharma needs will be required for DigiPath in an increasingly competitive landscape, particularly for hospitals - both community-based groups and academic medical centers to be successful. &nbsp;Check out their new website at <\/em><a href=\"http:\/\/www.digipath.biz\" target=\"_blank\"><em><a href=\"http:\/\/www.digipath.biz\" rel=\"nofollow\">http:\/\/www.digipath.biz<\/a><\/em><\/a><em> for more information.<\/em><\/span><\/p><p><span><a href=\"http:\/\/www.tissuepathology.com\/.a\/6a00e009846ac18833014e89a103c9970d-popup\"><img decoding=\"async\" alt=\"DigiPath\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/a3334_6a00e009846ac18833014e89a103c9970d-320wi\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> DigiPath, Inc.&trade; today announced its entry into the digital pathology market. DigiPath provides&nbsp;the next generation of affordable, innovative, and reliable digital pathology solutions. DigiPath&rsquo;s&nbsp;solutions will support community pathology practices, hospitals, academic medical centers,&nbsp;reference laboratories, biopharma organizations, and life science research institutions.<\/span><\/p><p><span>&ldquo;The medical community is looking for more affordable, innovative, and reliable digital pathology solutions to assist in enhancing patient care,&rdquo; commented Keith Kaplan, M.D., Editor, Digital Pathology Blog&trade; at <a href=\"http:\/\/www.tissuepathology.com\" target=\"_blank\">http:\/\/www.tissuepathology.com<\/a>. &ldquo;DigiPath seems well positioned to help our community practices expand digital pathology adoption.&rdquo;<\/span><\/p><p><span>&ldquo;In Jun<\/span><span>e 2010, we surveyed over 400 CLIA&trade; certified labs concerning digital pathology&nbsp;adoption&rdquo;, stated Jondavid Klipp, Publisher, Laboratory Economics&trade;. &ldquo;55% of the respondents said that digital pathology was too expensive. Affordability is an important concern to pathology&nbsp;laboratories.&rdquo;&nbsp;<\/span><\/p><p><span>&ldquo;The DigiPath team brings a combined 60 year experience within the digital pathology field&rdquo;,&nbsp;said Eric Stoppenhagen, Chief Executive Officer. &ldquo;Our team pioneered digital pathology by&nbsp;implementing over 500 installations worldwide. During the coming years, DigiPath will be&nbsp;providing affordable, innovative, and reliable digital pathology solutions.&rdquo;<\/span><\/p><p><span>About DigiPath, Inc.<\/span><\/p><p><span>DigiPath, Inc. provides the next generation of affordable, innovative, and reliable digital&nbsp;pathology solutions. DigiPath&rsquo;s advisors bring over 60 years combined expertise in pioneering&nbsp;digital pathology, implementing over 500 installations at community pathology practices,&nbsp;hospitals, academic medical centers, reference laboratories, biopharma organizations, and life&nbsp;science research institutions worldwide.<\/span><\/p><p><span>Visit <a href=\"http:\/\/www.digipath.biz\" target=\"_blank\">http:\/\/www.digipath.biz<\/a> monthly to see new solutions emerge during 2011.<\/span><\/p><p>&nbsp;<\/p><p><span>SAFE HARBOR STATEMENT<\/span><\/p><p><span>This Press Release may contain certain forward-looking statements within the meaning of the Securities Litigation Reform Act of&nbsp;1995. DigiPath has tried, whenever possible, to identify these forward-looking statements using words such as \"anticipates,\"&nbsp;\"believes,\" \"estimates,\" \"expects,\" \"plans,\" \"intends,\" \"potential\" and similar expressions. These statements reflect DigiPath's current&nbsp;beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and&nbsp;unknown risks, uncertainties and other factors which could cause DigiPath's actual results, performance or achievements to differ&nbsp;materially from those expressed in or implied by such statements. DigiPath undertakes no obligation to update or provide advice in&nbsp;the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking&nbsp;statements.<\/span><\/p><p>&nbsp;<\/p><p>&nbsp;<\/p><p>&nbsp;<\/p><p>&nbsp;<\/p><\/div><div><a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=i1194rbqpns:p0Vapnx5Ltw:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/a3334_DigitalPathologyBlog?d=yIl2AUoC8zA\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=i1194rbqpns:p0Vapnx5Ltw:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/2ac12_DigitalPathologyBlog?i=i1194rbqpns:p0Vapnx5Ltw:F7zBnMyn0Lo\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=i1194rbqpns:p0Vapnx5Ltw:7Q72WNTAKBA\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/2ac12_DigitalPathologyBlog?d=7Q72WNTAKBA\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=i1194rbqpns:p0Vapnx5Ltw:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/2ac12_DigitalPathologyBlog?i=i1194rbqpns:p0Vapnx5Ltw:V_sGLiPBpWU\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=i1194rbqpns:p0Vapnx5Ltw:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/590ab_DigitalPathologyBlog?d=qj6IDK7rITs\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=i1194rbqpns:p0Vapnx5Ltw:l6gmwiTKsz0\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/590ab_DigitalPathologyBlog?d=l6gmwiTKsz0\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=i1194rbqpns:p0Vapnx5Ltw:gIN9vFwOqvQ\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/590ab_DigitalPathologyBlog?i=i1194rbqpns:p0Vapnx5Ltw:gIN9vFwOqvQ\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=i1194rbqpns:p0Vapnx5Ltw:TzevzKxY174\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/590ab_DigitalPathologyBlog?d=TzevzKxY174\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a><\/div><p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/fa089_i1194rbqpns\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\"><\/p>","protected":false},"excerpt":{"rendered":"<p>A new digital pathology vendor hits the market today. &nbsp;Affordable and innovative solutions to meet both clinical and research\/biopharma needs will be required for DigiPath in an increasingly competitive landscape, particularly for hospitals - both community-based groups and academic medical &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/new-digital-pathology-vendor-welcome-to-digipath-inc.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-245500","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245500"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=245500"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245500\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=245500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=245500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=245500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}